Functional dissection of the HNF-1alpha transcription factor: A study on nuclear localization and transcriptional activation

DNA and Cell Biology

Volumn 24, Issue 11, 2005, Pages 661-669

  Bjørkhaug, Lise ^a   Bratland, André ^a   Njølstad, Pål Rasmus ^a,b   Molven, Anders ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; LIVER; MATURITY ONSET DIABETES MELLITUS; PANCREAS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TCF1 GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CELL COMPARTMENTATION; GENES, REPORTER; HELA CELLS; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR LOCALIZATION SIGNALS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SUBCELLULAR FRACTIONS; TRANS-ACTIVATION (GENETICS);

EID: 28444436600     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.661     Document Type: Article

References (37)

1. BAN, N., YAMADA, Y., SOMEYA, Y., MIYAWAKI, K., IHARA, Y., HOSOKAWA, M., TOYOKUNI, S., TSUDA, K., and SEINO, Y. (2002). Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51, 1409-1418.
2. BJØRKHAUG, L., YE, H., HORIKAWA, Y., SØVIK, O., MOLVEN, A., and NJØLSTAD, P.R. (2000). MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X). Biochem. Biophys. Res. Commun. 279, 792-798.
3. BJØRKHAUG, L., SAGEN, J.V., THORSBY, P., SØVIK, O., MOLVEN, A., and NJØLSTAD, P.R. (2003). Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. J. Clin. Endocrinol. Metab. 88, 920-931.
4. BOJ, S.F., PARRIZAS, M., MAESTRO, M.A., and FERRER, J. (2001). A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl. Acad. Sci. USA 98, 14481-14486.
5. BOULIKAS, T. (1994). Putative nuclear localization signals (NLS) in protein transcription factors. J. Cell. Biochem. 55, 32-58.
6. CARMO-FONSECA, M., MENDES-SOARES, L., and CAMPOS, I. (2000). To be or not to be in the nucleolus. Nat. Cell Biol. 2, E107-E112.
7. CARRIERE, C., PLAZA, S., CABOCHE, J., DOZIER, C., BAILLY, M., MARTIN, P., and SAULE, S. (1995). Nuclear localization signals, DNA binding, and transactivation properties of quail Pax-6 (Pax-QNR) isoforms. Cell Growth Differ. 6, 1531-1540.
8. CEREGHINI, S. (1996). Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10, 267-282.
9. CHI, Y.I., FRANTZ, J.D., OH, B.C., HANSEN, L., DHE-PAGANON, S., and SHOELSON, S.E. (2002). Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol. Cell. 10, 1129-1137.
10. DINGWALL, C., and LASKEY, R.A. (1991). Nuclear targeting sequences-A consensus? Trends Biochem. Sci. 16, 478-481.
11. DINGWALL, C., ROBBINS, J., DILWORTH, S.M., ROBERTS, B., and RICHARDSON, W.D. (1988). The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J. Cell Biol. 107, 841-849.
12. DWORETZKY, S.I, LANFORD, R.E., and FELDHERR, C.M. (1988). The effects of variations in the number and sequence of targeting signals on nuclear uptake. J. Cell Biol. 107, 1279-1287.
13. ETHERIDGE, K.T., BANIK, S.S., ARMBRUSTER, B.N., ZHU, Y., TERNS, R.M., TERNS, M.P., and COUNTER, C.M. (2002). The nucleolar localization domain of the catalytic subunit of human telomerase. J. Biol. Chem. 277, 24764-24770.
14. FRAYLING, T.M., EVANS, J.C., BULMAN, M.P., PEARSON, E., ALLEN, L., OWEN, K., BINGHAM, C., HANNEMANN, M., SHEPHERD, M., ELLARD, S., et al. (2001). Beta-cell genes and diabetes: Molecular and clinical characterization of mutations in transcription factors. Diabetes 50(Suppl 1), S94-100.
15. HALL, M.N., CRAIK, C., and HIRAOKA, Y. (1990). Homeodomain of yeast repressor alpha 2 contains a nuclear localization signal. Proc. Natl. Acad. Sci. USA 87, 6954-6958.
16. HESSABI, B., ZIEGLER, P., SCHMIDT, I., HESSABI, C., and WALTHER, R. (1999). The nuclear localization signal (NLS) of PDX-1 is part of the homeodomain and represents a novel type of NLS. Eur. J. Biochem. 263, 170-177.
17. MAKKERH, J.P., DINGWALL, C., and LASKEY, R.A. (1996). Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids. Curr Biol. 6, 1025-1027.
18. MEISEL, L., and LAM, E. (1996). The conserved ELK-homeodomain of KNOTTED-I contains two regions that signal nuclear localization. Plant Mol. Biol. 30, 1-14.
19. NICOSIA, A., MONACI, P., TOMEI, L., DE FRANCESCO, R., NUZZO, M., STUNNENBERG, H., and CORTESE, R. (1990). A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 61, 1225-1236.
20. NIE, Y., ZHAO, Q., SU, Y., and YANG, J.H. (2004). Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif. J. Biol. Chem. 279, 13249-13255.
21. POLEEV, A., OKLADNOVA, O., MUSTI, A.M., SCHNEIDER, S., ROYER-POKORA, B., and PLACHOV, D. (1997). Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential. Eur. J. Biochem. 247, 860-869.
22. PONTOGLIO, M., PAUSA, M., DOYEN, A., VIOLLET, B., YANIV, M., and TEDESCO, F. (2001). Hepatocyte nuclear factor 1alpha controls the expression of terminal complement genes. J. Exp. Med. 194, 1683-1689.
23. RANEY, A.K., EASTON, A.J., MILICH, D.R., and MCLACHLAN, A. (1991). Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J. Virol. 65, 5774-5781.
24. ROBBINS, J., DILWORTH, S.M., LASKEY, R.A., and DINGWALL, C. (1991). Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence. Cell 64, 615-623.
25. RYFFEL, G.U. (2001). Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences. J. Mol. Endocrinol. 27, 11-29.
26. SHIH, D.Q., SCREENAN, S., MUNOZ, K.N., PHILIPSON, L., PONTOGLIO, M., YANIV, M., POLONSKY, K.S., and STOFFEL, M. (2001). Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50, 2472-2480.
27. SOCK, E., ENDERICH, J., ROSENFELD, M.G., and WEGNER, M. (1996). Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem. 271, 17512-17518.
28. SOURDIVE, D.J., CHOUARD, T., and YANIV, M. (1993). The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. C R Acad Sci III 316, 385-394.
29. THOMAS, H., BADENBERG, B., BULMAN, M., LEMM, L, LAUSEN, J., KIND, L., ROOSEN, S., ELLARD, S., HATTERSLEY, A.T. and RYFFEL, G.U. (2002). Evidence for haploinsufficiency of the human HNF1 alpha gene revealed by functional characterization of MODY3-associated mutations. Biol. Chem. 383, 1691-1700.
30. TIAN, J.M., and SCHIBLER, U. (1991). Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev. 5, 2225-2234.
31. TOMURA, H., NISHIGORI, H., SHO, K., YAMAGATA, K., INOUE, I., and TAKEDA, J. (1999). Loss-of-function and dominant-negative mechanisms associated with hepatocyte nuclear factor-1beta mutations in familial type 2 diabetes mellitus. J. Biol. Chem. 274, 12975-12978.
32. VAXILLAIRE, M., ABDERRAHMANI, A., BOUTIN, P., BAILLEUL, B., FROGUEL, P., YANIV, M., and PONTOGLIO, M. (1999). Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem. 274, 35639-35646.
33. WU, G., BOHN, S., and RYFFEL, G.U. (2004). The HNF1beta transcription factor has several domains involved in nephrogenesis and partially rescues Pax8/lim1-induced kidney malformations. Eur. J. Biochem. 271, 3715-3728.
34. WU, K.J., WILSON, D.R., SHIH, C., and DARLINGTON, GJ. (1994). The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain. J. Biol. Chem. 269, 1177-1182.
35. YAMADA, H., JIANG, Y.M., ZHU, H.Y., INAGAKI-OHARA, K., and NISHIYAMA, Y. (1999a). Nucleolar localization of the UL3 protein of herpes simplex virus type 2. J. Gen. Virol. 80(Pt 8), 2157-2164.
36. YAMADA, S., TOMURA, H., NISHIGORI, H., SHO, K., MABE, H., IWATANI, N., TAKUMI, T., KITO, Y., MORIYA, N., MUROYA, K., et al. (1999b). Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes 48, 645-648.
37. YAMAGATA, K., YANG, Q., YAMAMOTO, K., IWAHASHI, H., MIYAGAWA, J., OKITA, K., YOSHIUCHI, I., MIYAZAKI, J., NOGUCHI, T., NAKAJIMA, H., et al. (1998). Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes. 47, 1231-1235.